[Interferons: between structure and function]
- PMID: 24864095
- DOI: 10.5604/17322693.1101229
[Interferons: between structure and function]
Abstract
Interferons are a family of proteins that are released by a variety of cells in response to infections caused by viruses. Currently, we distinguish three types of interferons. They are classified based on the nucleotide sequence, interaction with specific receptors, chromosomal location, structure and physicochemical properties. The following interferons are classified as type I: α, β, ω, κ, ε, ζ, τ, δ, ν. They are recognized and bound by a receptor formed by two peptides, IFN-αR1 and IFN-αR2. Representative of type II interferons is interferon-γ. It binds to a receptor composed of chains IFNGR-1 and IFNGR-2. The recently classified type III interferons comprise IFN-λ1, IFN-λ2, and IFN-λ3. They act on receptors formed by λR1 IFN-and IL-10R2 subunits. A high level of antiviral protection is achieved by IFN-α, IFN-β and IFN-λ. Antiviral activity of interferons is based on the induction and regulation of innate and acquired immune mechanisms. By binding to transmembrane receptors, IFN interacts with target cells mainly by activating the JAK/STAT, but also other signaling pathways. This leads to induction and activation of many antiviral agents, such as protein kinase RNA-activated (PKR), ribonuclease 2-5A pathway, and Mx proteins, as well as numerous apoptotic pathways. As a result of the protective effect of interferons, the virus binding to cells and viral particles penetration into cells is stopped, and the release of the nucleocapsid from an envelope is suppressed. Disruption of transcription and translation processes of the structural proteins prevents the formation of virions or budding of viruses, and as a result degradation of the viral mRNA; the started processes inhibit the chain synthesis of viral proteins and therefore further stimulate the immune system cells.
Similar articles
-
Induction and regulation of IFNs during viral infections.J Interferon Cytokine Res. 2004 Aug;24(8):439-54. doi: 10.1089/1079990041689665. J Interferon Cytokine Res. 2004. PMID: 15320958 Review.
-
Interferons lambda, new cytokines with antiviral activity.Acta Virol. 2013;57(2):171-9. doi: 10.4149/av_2013_02_171. Acta Virol. 2013. PMID: 23600875 Review.
-
The interferon system of teleost fish.Fish Shellfish Immunol. 2006 Feb;20(2):172-91. doi: 10.1016/j.fsi.2005.01.010. Fish Shellfish Immunol. 2006. PMID: 15939626 Review.
-
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.Nat Immunol. 2003 Jan;4(1):69-77. doi: 10.1038/ni875. Epub 2002 Dec 16. Nat Immunol. 2003. PMID: 12483210
-
Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.J Virol. 2001 Apr;75(8):3802-10. doi: 10.1128/JVI.75.8.3802-3810.2001. J Virol. 2001. PMID: 11264369 Free PMC article.
Cited by
-
Changes in interferon-gamma and neopterin in female dogs undergoing ovariohysterectomy as elective spay or as treatment of pyometra.Can J Vet Res. 2020 Jul;84(3):230-234. Can J Vet Res. 2020. PMID: 32801459 Free PMC article.
-
Bacillus amyloliquefaciens TL Downregulates the Ileal Expression of Genes Involved in Immune Responses in Broiler Chickens to Improve Growth Performance.Microorganisms. 2021 Feb 13;9(2):382. doi: 10.3390/microorganisms9020382. Microorganisms. 2021. PMID: 33668643 Free PMC article.
-
Anti-HBV effect of interferon-thymosin α1 recombinant proteins in transgenic Dunaliella salina in vitro and in vivo.Exp Ther Med. 2018 Aug;16(2):517-522. doi: 10.3892/etm.2018.6227. Epub 2018 May 29. Exp Ther Med. 2018. PMID: 30112022 Free PMC article.
-
Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel.Postepy Dermatol Alergol. 2022 Oct;39(5):913-922. doi: 10.5114/ada.2022.120884. Epub 2022 Nov 9. Postepy Dermatol Alergol. 2022. PMID: 36457677 Free PMC article.
-
IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathway.Biomed Res Int. 2015;2015:959684. doi: 10.1155/2015/959684. Epub 2015 Mar 16. Biomed Res Int. 2015. PMID: 25861653 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials